Prostate Cancer - Results from #28640

High-intensity focused ultrasound (HIFU) in prostate cancer: A single centre experience in patients with low, intermediate or high-risk of progression - Abstract March 21, 2011

Lifestyle intervention in men with advanced prostate cancer receiving androgen suppression therapy: A feasibility study - Abstract March 18, 2011

Impact of clinical parameters on the diagnostic accuracy of endorectal coil MRI for the detection of prostate cancer - Abstract March 18, 2011

Intensity-modulated radiotherapy with simultaneous integrated boost to dominant intraprostatic lesion: Preliminary report on toxicity - Abstract March 18, 2011

Optimal management of bone metastases in prostate cancer - Abstract March 18, 2011

Second-line chemotherapy in metastatic docetaxel-resistant prostate cancer: A review - Abstract March 18, 2011

Factors influencing men's decisions regarding prostate cancer screening: A qualitative study - Abstract March 18, 2011

Effect of finasteride on the sensitivity of PSA to detect prostate cancer in rebiopsy series - Abstract March 18, 2011

Smarter screening for prostate cancer: For the few, not the many? A stratified approach based on baseline risk - Abstract March 18, 2011

The incidence of transition zone prostate cancer diagnosed by transperineal template-guided mapping biopsy: Implications for treatment planning - Abstract March 17, 2011

Quality of life among men with prostate cancer in rural Georgia - Abstract March 17, 2011

Prostate cancer incidence and disease-specific survival of men with initial prostate-specific antigen less than 3.0ng/ml who are participating in ERSPC Rotterdam - Abstract March 17, 2011

A systematic review of psychosocial interventions for men with prostate cancer and their partners - Abstract March 17, 2011

Testosterone therapy in men with untreated prostate cancer - Abstract March 17, 2011

Zoledronic acid induces autophagic cell death in human prostate cancer cells - Abstract March 17, 2011

Nuclear localization of factor inhibitor hypoxia-inducible factor in prostate cancer is associated with poor prognosis - Abstract March 17, 2011

Survivin is associated with cell proliferation and has a role in 1a,25-dihydroxyvitamin D(3) induced cell growth inhibition in prostate cancer - Abstract March 17, 2011

Phase II evaluation of early oral estramustine, oral etoposide, and intravenous paclitaxel combined with hormonal therapy in patients with high-risk metastatic prostate adenocarcinoma: Southwest Oncology Group S0032 - Abstract March 17, 2011

Prostate cancer gene 3 urine assay for prostate cancer in Japanese men undergoing prostate biopsy - Abstract March 16, 2011

Industry-based retrospective cohort study of the risk of prostate cancer among rotating-shift workers - Abstract March 16, 2011

Page 1433 of 1447